Importance of killer immunoglobulin-like receptors in allogeneic hematopoietic stem cell transplantation

Revista Brasileira de Hematologia e Hemoterapia

Volumn 33, Issue 2, 2011, Pages 126-130

  Franceschi, Danilo Santana Alessio ^a   de Souza, Cármino Antonio ^b   Aranha, Francisco José Penteado ^b   Cardozo, Daniela Maira ^a   Sell, Ana Maria ^a   Visentainer, Jeane Eliete Laguila ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Graft vs host disease; Hematopoietic stem cell transplantation; Histocompatibility testing; HLA antigens; Killer cells; Natural; Receptor KIR immunology

Indexed keywords

EID: 79959824428     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: 10.5581/1516-8484.20110033     Document Type: Review

References (35)

1. Moretta A, Marcenaro E, Parolini S, Ferlazzo G, Moretta L. NK cells at the interface between innate and adaptive immunity. Cell Death Differ. 2008;15(2):226-33.
2. Andoniou CE, Andrews DM, Degli-Esposti MA. Natural killer cells in viral infection: more than just killers. Immunol Rev. 2006; 214:239-50.
3. Gardiner CM. Killer cell immunoglobulin-like receptors on NK cells: the how, where and why. Int J Immunogenet. 2008;35(1):1-8.
4. Rajagopalan S, Long EO. Understanding how combinations of HLA and KIR genes influence disease. J Exp Med. 2005;201(7):1025-9.
5. McVicar DW, Burshtyn DN. Intracellular signaling the killer immunoglobulin-like receptors and Ly49. Sci STKE. 2001;(75):re1.
6. Rajagopalan S, Long EO. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med. 1999;189(7):1093-100. Erratum in: J Exp Med 2000;191(11): following 2027.
7. O'Connor GM, Hart OM, Gardiner CM. Putting the natural killer cell in its place. Immunology. 2006;117(1):1-10.
8. Boyton RJ, Altmann DM. Natural killer cells, killer immunoglobulinlike receptors and human leukocyte antigen class I in disease. Clin Exp Immunol. 2007;149(1):1-8.
9. Katz G, Markel G, Mizrahi S, Arnon TI, Mandelboim O. Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4. J Immunol. 2001;166(12):7260-7.
10. Laguila Visentainer JE, Lieber SR, Lopes Persoli LB, Dutra Marques SB, Vigorito AC, Penteado Aranha FJ, et al. Relationship between cytokine gene polymorphisms and graft-versus-host disease after allogeneic stem cell transplantation in a Brazilian population. Cytokine. 2005;32(3-4):171-7.
11. Viel DO, Tsuneto LT, Sossai CR, Lieber SR, Marques SB, Vigorito AC, et al. IL2 and TNFA gene polymorphisms and the risk of graft versus host disease after allogeneic stem cell transplantation. Scand J Immunol. 2007;66(6):703-10.
12. Vizoni SL, Lieber SR, de Souza CA, Sell AM, Visentainer JE. Papel das citocinas na imunopatogênese da doença do enxerto contra o hospedeiro. Rev Bras Hematol Hemoter. 2008;30(2):142-52.
13. Koh LP, Rizzieri DA, Chao NJ. Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors. Biol Blood Marrow Transplant. 2007;13(11):1249-67.
14. Kärre K. Immunology. A perfect mismatch. Science. 2002;295 (5562):2029-31. Comment on: Science. 2002;295(5562):2097-100; Science. 2002;295(5562):2094-7.
15. Ruggeri L, Capanni M, Casucci M, Volpi I, Tosti A, Perruccio K, et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood. 1999;94(1):333-9.
16. Ruggeri L, Capanni M, Urbani, E, Perruccio, K, Shlomchik WD, Tosti A, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295(5562): 2097-100. Comment in: Science. 2002;295 (5562):2029-31.
17. Bishara A, De Santis D, Witt CC, Brautbar C, Christiansen FT, Or R, et al. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreative T cells causing GVHD. Tissue Antigens. 2004;63(3):204-11.
18. Miller JS, Soignier Y, Panoskaltsis-Mortari A, McNearney SA, Yun GH, Fautsch SK, et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood. 2005;105(8):3051-7.
19. Keller MD, Chen DF, Condron SA, Liu N, Reinsmoen NL, Buckey RH. The effect of natural killer cell killer Ig-like receptor alloreactivity on the outcome of bone marrow stem cell transplantation for severe combined immunodeficiency (SCID). J Clin Immunol. 2007;27(1): 109-16. Erratum in: J Clin Immunol. 2007;27(6):659.
20. Ruggeri L, Mancusi A, Capanni M, Urbani E, Carotti A, Aloisi T, et al. Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. Blood. 2007;110(1):433-40.
21. Ruggeri L, Aversa F, Martelli MF, Velardi A. Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. Immunol Rev. 2006;214:202-18.
22. Cook MA, Milligan DW, Fegan CD, Darbyshire PJ, Mahendra P, Craddock CF, et al. The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. Blood. 2004;103(4):1521-6.
23. Witt CS, Christiansen FT. The relevance of natural killer cell human leukocyte antigen epitopes and killer cell immunoglobulinlike receptors in bone marrow transplantation. Vox Sang. 2006; 90(1):10-20.
24. Hsu KC, Keever-Taylor CA, Wilton A, Pinto C, Heller G, Arkun K, et al. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood. 2005; 105(12):4878-84.
25. Schellekens J, Rozemuller EH, Petersen EJ, van den Tweel JG, Verdonck LF, Tilanus MG. Activating KIRs exert a crucial role on relapse and overall survival after HLA-identical sibling transplantation. Mol Immunol. 2008;45(8):2255-61.
26. Instituto Nacional de Câncer. Registro nacional de doadores de medula óssea (REDOME). Brasília: INCA; 2011. [cited 2011 Jan 12]. Available from: http://www.inca.gov.br/conteudo_view.asp?ID=677.
27. Davies SM, Ruggieri L, DeFor T, Wagner JE, Weisdorf DJ, Miller JS, et al. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Blood. 2002;100(10):3825-7.
28. Giebel S, Locatelli F, Lamparelli T, Velardi A, Davies S, Frumento G, et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood. 2003;102(3):814-9.
29. Bornhauser M, Schwerdtfeger R, Martin H, Frank KH, Theuser C, Ehninger G. Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors. Blood. 2004; 103(7):2860-1; author reply 2862. Comment on: Blood. 2003; 102(3):814-9.
30. Beelen DW, Ottinger HD, Ferencik S, Elmaagacli AH, Peceny R, Trenschel R, et al. Genotypic inhibitory killer immunoglobulinlike receptor ligand incompatibility enhances the long term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias. Blood. 2005;105(6):2594-600.
31. De Santis D, Bishara A, Witt CS, Nagler A, Brautbar C, Slavin S, et al. Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants. Tissue Antigens. 2005;65(6):519-28.
32. Hsu KC, Gooley T, Malkki M, Pinto-Agnello C, Dupont B, Bignon JD, Bornhäuser M, Christiansen F, Gratwohl A, Morishima Y, Oudshoorn M, Ringden O, van Rood JJ, Petersdorf E; International Histocompatibility Working Group. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy. Biol Blood Marrow Transplant. 2006;12(8):828-36.
33. Farag SS, Bacigalupo A, Eapen M, Hurley C, Dupont B, Caligiuri MA, Boudreau C, Nelson G, Oudshoorn M, van Rood J, Velardi A, Maiers M, Setterholm M, Confer D, Posch PE, Anasetti C, Kamani N, Miller JS, Weisdorf D, Davies SM; KIR Study Group, Center for International Blood and Marrow Transplantation Research. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and Dutch registry. Biol Blood Marrow Transplant. 2006;12(8):876-84.
34. Giebel S, Nowak I, Wojnar J, Markiewicz M, Dziaczkowska J, Wylezol I, et al. Impact of activating killer immunoglobulin-like receptor genotype on outcome of unrelated donor-hematopoietic cell transplantation. Transplant Proc. 2006;38(1):287-91.
35. Han M, Fallena M, Guo Y, Stastny, P. Natural killer cell crossmatch: functional analysis of inhibitory killer immunoglobulin-like receptors and their HLA ligands. Hum Immunol. 2007;68(6):507-13.